Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), the
Director-General of the New Zealand Food Safety Authority gives notice that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Dexdomitor
Reference: A10396
Active Ingredient and Concentration: Dexmedetomidine hydrochloride 0.5g/L
Formulation Type: Aqueous solution or suspension
General Use Claim: Sedative, analgesic for use in the restraint of dogs and cats.
Any person may make a written submission to the
director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general’s address for service:
ACVM Group, New Zealand Food Safety
Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.
The applicant’s address for service is:
Pfizer New Zealand Limited, Level 3, Pfizer House,
14 Normanby Road, Mt Eden, Auckland 1024. Postal Address: PO Box 3998, Shortland Street, Auckland 1140.
Dated at Wellington this 23rd day of October 2009.
MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority), New Zealand Food Safety Authority.